A citation-based method for searching scientific literature

C Neill Epperson, Meir Steiner, S Ann Hartlage, Elias Eriksson, Peter J Schmidt, Ian Jones, Kimberly A Yonkers. Am J Psychiatry 2012
Times Cited: 137







List of co-cited articles
813 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
P J Schmidt, L K Nieman, M A Danaceau, L F Adams, D R Rubinow. N Engl J Med 1998
448
33

Daily Record of Severity of Problems (DRSP): reliability and validity.
J Endicott, J Nee, W Harrison. Arch Womens Ment Health 2006
219
28

The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).
Uriel Halbreich, Jeff Borenstein, Terry Pearlstein, Linda S Kahn. Psychoneuroendocrinology 2003
266
25

The premenstrual symptoms screening tool (PSST) for clinicians.
M Steiner, M Macdougall, E Brown. Arch Womens Ment Health 2003
209
22

Premenstrual Dysphoric Disorder: Epidemiology and Treatment.
Liisa Hantsoo, C Neill Epperson. Curr Psychiatry Rep 2015
76
25

Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).
Tory A Eisenlohr-Moul, Susan S Girdler, Katja M Schmalenberger, Danyelle N Dawson, Pallavi Surana, Jacqueline L Johnson, David R Rubinow. Am J Psychiatry 2017
35
54


Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness.
Andrea J Rapkin, Sharon A Winer. Expert Rev Pharmacoecon Outcomes Res 2009
84
16

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
Pedro E Martinez, David R Rubinow, Lynnette K Nieman, Deloris E Koziol, A Leslie Morrow, Crystal E Schiller, Dahima Cintron, Karla D Thompson, Khursheed K Khine, Peter J Schmidt. Neuropsychopharmacology 2016
55
25

Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
Peter J Schmidt, Pedro E Martinez, Lynnette K Nieman, Deloris E Koziol, Karla D Thompson, Linda Schenkel, Paul G Wakim, David R Rubinow. Am J Psychiatry 2017
60
23

Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus.
Patrick Michael Shaughn O'Brien, Torbjorn Bäckström, Candace Brown, Lorraine Dennerstein, Jean Endicott, C Neill Epperson, Elias Eriksson, Ellen Freeman, Uriel Halbreich, Khaled M K Ismail,[...]. Arch Womens Ment Health 2011
116
13

Selective serotonin reuptake inhibitors for premenstrual syndrome.
Jane Marjoribanks, Julie Brown, Patrick Michael Shaughn O'Brien, Katrina Wyatt. Cochrane Database Syst Rev 2013
93
13

Emotion regulation in women with premenstrual dysphoric disorder.
Nicole Petersen, Edythe D London, Letty Liang, Dara G Ghahremani, Rachel Gerards, Linda Goldman, Andrea J Rapkin. Arch Womens Ment Health 2016
23
56

ISPMD consensus on the management of premenstrual disorders.
Tracy Nevatte, Patrick Michael Shaughn O'Brien, Torbjorn Bäckström, Candace Brown, Lorraine Dennerstein, Jean Endicott, C Neill Epperson, Elias Eriksson, Ellen W Freeman, Uriel Halbreich,[...]. Arch Womens Ment Health 2013
74
16

Premenstrual syndrome.
Kimberly Ann Yonkers, P M Shaughn O'Brien, Elias Eriksson. Lancet 2008
236
12

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
C Neill Epperson, Kristin Haga, Graeme F Mason, Edward Sellers, Ralitza Gueorguieva, Wenjiang Zhang, Erica Weiss, Douglas L Rothman, John H Krystal. Arch Gen Psychiatry 2002
250
11

Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Kimberly A Yonkers, Susan G Kornstein, Ralitza Gueorguieva, Brian Merry, Kari Van Steenburgh, Margaret Altemus. JAMA Psychiatry 2015
22
50

Oral contraceptives containing drospirenone for premenstrual syndrome.
Laureen M Lopez, Adrian A Kaptein, Frans M Helmerhorst. Cochrane Database Syst Rev 2012
80
13


Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
Erika Timby, Torbjörn Bäckström, Sigrid Nyberg, Hans Stenlund, Anna-Carin N Wihlbäck, Marie Bixo. Psychopharmacology (Berl) 2016
32
34

Reproductive Steroid Regulation of Mood and Behavior.
Crystal Edler Schiller, Sarah L Johnson, Anna C Abate, Peter J Schmidt, David R Rubinow. Compr Physiol 2016
71
15

Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets.
S Ann Hartlage, Sally Freels, Nathan Gotman, Kimberly Yonkers. Arch Gen Psychiatry 2012
39
25


Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Kimberly A Yonkers, Candace Brown, Teri B Pearlstein, Marie Foegh, Carole Sampson-Landers, Andrea Rapkin. Obstet Gynecol 2005
190
10

Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study.
Erica B Baller, Shau-Ming Wei, Philip D Kohn, David R Rubinow, Gabriela Alarcón, Peter J Schmidt, Karen F Berman. Am J Psychiatry 2013
50
20

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial.
Marie Bixo, Karin Ekberg, Inger Sundström Poromaa, Angelica Lindén Hirschberg, Aino Fianu Jonasson, Lotta Andréen, Erika Timby, Marianne Wulff, Agneta Ehrenborg, Torbjörn Bäckström. Psychoneuroendocrinology 2017
44
22

Allopregnanolone and mood disorders.
T Bäckström, M Bixo, M Johansson, S Nyberg, L Ossewaarde, G Ragagnin, I Savic, J Strömberg, E Timby, F van Broekhoven,[...]. Prog Neurobiol 2014
91
9

The effect of serotonin 1A receptor polymorphism on the cognitive function of premenstrual dysphoric disorder.
Ju-Yu Yen, Hung-Pin Tu, Cheng-Sheng Chen, Cheng-Fang Yen, Cheng-Yu Long, Chih-Hung Ko. Eur Arch Psychiatry Clin Neurosci 2014
21
42

Progesterone receptors: form and function in brain.
Roberta Diaz Brinton, Richard F Thompson, Michael R Foy, Michel Baudry, Junming Wang, Caleb E Finch, Todd E Morgan, Christian J Pike, Wendy J Mack, Frank Z Stanczyk,[...]. Front Neuroendocrinol 2008
395
9

Operationalizing DSM-IV criteria for PMDD: selecting symptomatic and asymptomatic cycles for research.
Mark J Smith, Peter J Schmidt, David R Rubinow. J Psychiatr Res 2003
38
23

Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
Teri B Pearlstein, Gloria A Bachmann, Howard A Zacur, Kimberly A Yonkers. Contraception 2005
144
9

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D V Sheehan, Y Lecrubier, K H Sheehan, P Amorim, J Janavs, E Weiller, T Hergueta, R Baker, G C Dunbar. J Clin Psychiatry 1998
9

Effects of gonadal steroids in women with a history of postpartum depression.
M Bloch, P J Schmidt, M Danaceau, J Murphy, L Nieman, D R Rubinow. Am J Psychiatry 2000
503
9

The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis.
Katrina M Wyatt, Paul W Dimmock, Khaled M K Ismail, Peter W Jones, P M Shaughn O'Brien. BJOG 2004
81
11

Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder.
Corey E Pilver, Becca R Levy, Daniel J Libby, Rani A Desai. Arch Womens Ment Health 2011
36
25

Addressing concerns about the inclusion of premenstrual dysphoric disorder in DSM-5.
S Ann Hartlage, Cynthia A Breaux, Kimberly A Yonkers. J Clin Psychiatry 2014
19
42

Update on research and treatment of premenstrual dysphoric disorder.
Joanne Cunningham, Kimberly Ann Yonkers, Shaughn O'Brien, Elias Eriksson. Harv Rev Psychiatry 2009
90
8

Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene.
Liang Huo, Richard E Straub, Catherine Roca, Peter J Schmidt, Kai Shi, Radhakrishna Vakkalanka, Daniel R Weinberger, David R Rubinow. Biol Psychiatry 2007
83
9

Hippocampal structural changes across the menstrual cycle.
Xenia Protopopescu, Tracy Butler, Hong Pan, James Root, Margaret Altemus, Margaret Polanecsky, Bruce McEwen, David Silbersweig, Emily Stern. Hippocampus 2008
144
8

Premenstrual dysphoric disorder: burden of illness and treatment update.
Teri Pearlstein, Meir Steiner. J Psychiatry Neurosci 2008
79
10

Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.
Teri Pearlstein, Kimberly A Yonkers, Rana Fayyad, John A Gillespie. J Affect Disord 2005
78
10


Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder.
Axel Perkonigg, Kimberly A Yonkers, Hildegard Pfister, Roselind Lieb, Hans-Ulrich Wittchen. J Clin Psychiatry 2004
81
9

Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder.
Malin Gingnell, Arvid Morell, Elin Bannbers, Johan Wikström, Inger Sundström Poromaa. Horm Behav 2012
65
12

Toward a functional neuroanatomy of premenstrual dysphoric disorder.
Xenia Protopopescu, Oliver Tuescher, Hong Pan, Jane Epstein, James Root, Luke Chang, Margaret Altemus, Margaret Polanecsky, Bruce McEwen, Emily Stern,[...]. J Affect Disord 2008
82
9

Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Peter J Schmidt, Rivka Ben Dor, Pedro E Martinez, Gioia M Guerrieri, Veronica L Harsh, Karla Thompson, Deloris E Koziol, Lynnette K Nieman, David R Rubinow. JAMA Psychiatry 2015
96
8

Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder.
Tory A Eisenlohr-Moul, David R Rubinow, Crystal E Schiller, Jacqueline L Johnson, Jane Leserman, Susan S Girdler. Psychoneuroendocrinology 2016
25
32

Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.
Cynthia Neill Epperson, Brian Pittman, Kathryn Ann Czarkowski, Stephanie Stiklus, John Harrison Krystal, Christian Grillon. Neuropsychopharmacology 2007
52
15

Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review.
Simone Toffoletto, Rupert Lanzenberger, Malin Gingnell, Inger Sundström-Poromaa, Erika Comasco. Psychoneuroendocrinology 2014
153
8

Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder.
Susan S Girdler, Jane Leserman, Robertas Bunevicius, Rebecca Klatzkin, Cort A Pedersen, Kathleen C Light. Health Psychol 2007
39
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.